4D Molecular Therapeutics
FDMT
12.20
-0.39
-3.10%
4D Molecular Therapeutics
US · FDMT
#3519 by market cap
Listed 2020
12.20
-0.39
-3.10%
Live - 5344 symbols - heartbeat 84s ago
· 2026-10-08 10:10
Pre-market
12.00
-4.69%
After-hours
12.59
0.00%
- Market cap
- 673.98M
- P/E (TTM)i
- -4.64
- P/Bi
- 1.65
- EPSi
- -2.42
- Div yieldi
- 0.00%
- 52W posi
- 53%
Reader sentiment
Are you bullish or bearish on FDMT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Institutional ownership
- Held by institutions
- 106.56% -0.76pp
- Institutions
- 190 +2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund49.76%
Hedge Fund27.02%
VC/PE Fund17.60%
Public Company9.60%
Individual/Insider2.84%
Private Company1.39%
Insurance Company0.89%
Government Pension Fund0.25%
Top holders as of 2026-06-30
Janus Henderson Group plc
10.40% · 5.75M sh
RA Capital Management, L.P.
9.14% · 5.05M sh
BlackRock
8.23% · 4.55M sh
The Goldman Sachs Group, Inc.
6.95% · 3.84M sh
Novo Holdings A/S
5.88% · 3.25M sh
State Street Global Advisors
5.27% · 2.91M sh
BVF Partners L.P.
5.21% · 2.88M sh
T. Rowe Price Group, Inc.
4.65% · 2.57M sh
Vanguard Capital Management, LLC
4.30% · 2.38M sh
Adage Capital Management, L.P.
4.07% · 2.25M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 20 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| David Kirn | Chief Executive Officer | 2.48% |
| John Milligan | Executive Chairperson | 0.18% |
| Ashoo Gupta | Principal Accounting Officer & Principal Financial Officer | 0.09% |
| Charles Theuer | Independent Director | 0.08% |
| Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | 0.02% |
| Fariborz Kamal | President | 0.01% |
| Glenn Sblendorio | Director | -- |
| Robert Kim | Chief Medical Officer | -- |
| BVF Partners L.P. | -- | -- |
| RA Capital Management, L.P. | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | David Kirn | Chief Executive Officer | Intent to Sell (Form 144) | -58,333 | $12.92 |
| 2026-09-15 | Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | Derivative Exercise and Sale | -1,635 | $4.14–13.65 |
| 2026-09-13 | David Kirn | Chief Executive Officer | Automatic Disposition | -58,333 | $13.90 |
| 2026-08-31 | Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | Derivative Exercise and Sale | -584 | $6.49–14.00 |
| 2026-08-18 | David Kirn | Chief Executive Officer | Automatic Disposition | -19,076 | $16.42 |
| 2026-08-18 | David Kirn | Chief Executive Officer | Derivative Exercise and Sale | -50,000 | $4.14–16.42 |
| 2026-08-16 | Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | Derivative Exercise and Sale | -3,270 | $4.14–12.20 |
| 2026-08-03 | David Kirn | Chief Executive Officer | Automatic Disposition | -26,842 | $10.23 |
| 2026-08-02 | David Kirn | Chief Executive Officer | Automatic Disposition | -12,415 | $10.05 |
| 2026-07-09 | David Kirn | Chief Executive Officer | Open Market Disposition | -58,333 | $12.01–12.87 |
| 2026-07-09 | David Kirn | Chief Executive Officer | Intent to Sell (Form 144) | -15,725 | $12.31 |
| 2026-07-08 | David Kirn | Chief Executive Officer | Intent to Sell (Form 144) | -42,608 | $12.89 |
| 2026-06-29 | Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | Derivative Exercise and Sale | -6,566 | $4.14–14.00 |
| 2026-06-22 | Scott Bizily | Chief Legal & Human Resources Officer and Corporate Secretary | Derivative Exercise and Sale | -9,810 | $4.14–12.00 |
| 2026-06-21 | David Kirn | Chief Executive Officer | Automatic Disposition | -114,746 | $10.47 |
| 2026-06-16 | Glenn Sblendorio | Director | Other Derivative Acquisition | +50,000 | $9.42 |
| 2026-06-16 | John Milligan | Executive Chairperson | Other Derivative Acquisition | +75,000 | $9.42 |
| 2026-06-16 | Charles Theuer | Independent Director | Other Derivative Acquisition | +50,000 | $9.42 |
| 2026-06-16 | Susannah Gray | Independent Director | Other Derivative Acquisition | +50,000 | $9.42 |
| 2026-06-16 | Jacob Chacko | Independent Director | Other Derivative Acquisition | +50,000 | $9.42 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:10:14 · For reference only, not investment advice and not tailored to your situation.